Despite COVID-19, Expert Group Moves Ahead With Public Meeting On Pediatric Device Development

While the US FDA has been developing a framework over the past few years to address the lack of pediatric devices on the market, the agency awarded a grant to the multi-stakeholder group C-Path to continue that work at the same time that the coronavirus pandemic started. Despite the hurdles, C-Path says it is still doing its work and plans to convene a public meeting on the issue in September.

Health Care teddy bear Heart stethoscope with filter effect retro vintage style

While the ongoing COVID-19 crisis is hampering the work of many organizations, the Critical Path Institute (C-Path) says it still plans to hold a public meeting in September and is moving ahead with bringing expert stakeholders together to try to solve the longstanding problem of developing medical devices for children.

C-Path is a public-private partnership of industry, academic and government experts who tend to work on developing new approaches and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation